Stories
Stocks in Focus: Fortis Healthcare, Unichem Labs, Prestige Estates, Signature Global & More on Sept 28
M
Moneycontrol•28-09-2026, 07:06
Stocks in Focus: Fortis Healthcare, Unichem Labs, Prestige Estates, Signature Global & More on Sept 28
- •Clean Max Enviro Energy Solutions: Augment India I Holdings LLC to sell 7.25% stake worth Rs 1,062.8 crore.
- •Unichem Laboratories: USFDA inspection at Goa facility concluded with five observations for procedural enhancements.
- •Aequs: Board approved preferential issue of up to 2.8 crore warrants to Mellwood Trustee Services for Rs 650 crore.
- •Signatureglobal (India): Acquired 194.22 acres in Gurugram, adding 6.77 million sq ft developable area with an estimated GDV of Rs 5,500-6,000 crore.
- •Fortis Healthcare: Defended its position in the Daiichi Sankyo dispute, stating it was a ‘complete stranger’ to the underlying dispute and had no role in the alleged dissipation of the erstwhile promoters' shareholding.
Key Questions Answered
Signatureglobal (India) acquired a land parcel of approximately 194.22 acres in Farrukhnagar, Gurugram, which adds an estimated developable area of about 6.77 million square feet to its development pipeline and has a gross development value of Rs 5,500-6,000 crore.
Fortis Healthcare defended its position by stating it was a complete stranger to the underlying dispute between Daiichi Sankyo and the Singh Brothers, and had no role in the alleged dissipation of shareholding.
The USFDA conducted an on-site inspection of Zydus Lifesciences' pharmacovigilance and post-marketing surveillance systems in New Jersey from September 22 to 25, 2026, which concluded with nil observations.
